The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.

Edward J D WebbDaniel HowdonRebecca BestwickNatalie KingJonathan A T Sandoe Joanne Euden Detelina GrozevaRobert WestPhilip Howard Neil PowellMahableshwar AlburStuart Evan BondLucy Brookes-HowellPaul DarkThomas HellyerMartin LlewelynIain J McCullaghMargaret OgdenPhilip PallmannHelena ParsonsDavid G PartridgeDominick ShawTamas SzakmanyStacy ToddEmma Thomas-JonesEnitan D CarrolBethany Shinkinsnull null

Published in: The Journal of antimicrobial chemotherapy (2024)

Using PCT to guide antibiotic therapy in individuals hospitalized with COVID-19 is more likely to be cost-effective than not, albeit with uncertainty.

Keyphrases

coronavirus disease
sars cov
primary care
respiratory syndrome coronavirus
stem cells
adverse drug
electronic health record